Back to top

VYNE Therapeutics announces 1-for-50 reverse stock split

VYNE Therapeutics (VYNE) announced that its board of directors has approved a reverse stock split of VYNE’s common stock at a ratio of 1-for-50 in ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

VYNE Therapeutics Inc. (VYNE)